CSVAX | VIHAX | CSVAX / VIHAX | |
Total Expense Ratio | 1.20 | 0.17 | 706% |
Annual Report Gross Expense Ratio | 1.30 | 0.17 | 765% |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 15.356 | 18.133 | 85% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 574M | 11B | 5% |
Annual Yield % from dividends | 2.06 | 4.14 | 50% |
Returns for 1 year | 8.06 | 16.95 | 48% |
Returns for 3 years | 35.64 | 37.14 | 96% |
Returns for 5 years | 41.06 | 62.69 | 65% |
Returns for 10 years | 36.12 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLEMX | 39.53 | N/A | N/A |
Harding Loevner Emerging Markets Advisor | |||
MGBRX | 17.18 | -0.15 | -0.87% |
MFS Global Total Return R2 | |||
VFIAX | 552.96 | -6.22 | -1.11% |
Vanguard 500 Index Admiral | |||
JHJIX | 23.11 | -0.34 | -1.45% |
JHancock ESG Large Cap Core I | |||
ANOCX | 15.75 | -0.27 | -1.69% |
American Century Small Cap Growth C |